The Amount of Evidence Needed to Support ERBB2 as a...

  • Main
  • 2019 / 08
  • The Amount of Evidence Needed to Support ERBB2 as a...
JAMA Oncology 2019 / 08

The Amount of Evidence Needed to Support ERBB2 as a Biomarker for Resistance to EGFR Inhibitors in Metastatic Colorectal Cancer

Sartore-Bianchi, Andrea, Marsoni, Silvia, Siena, Salvatore
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
JAMA Oncology
DOI:
10.1001/jamaoncol.2019.2982
Date:
August, 2019
File:
PDF, 47 KB
english, 2019
Conversion to is in progress
Conversion to is failed